Age
Item
patient is > 18 years of age (or minimum age as required by local regulations).
boolean
C0001779 (UMLS CUI [1])
Informed Consent | Patient data Release of information consent
Item
the patient has consented to participate by signing the "patient informed consent form" and/or has authorized the collection and release of his medical information by signing the "patient data release consent form".
boolean
C0021430 (UMLS CUI [1])
C2707520 (UMLS CUI [2,1])
C3166272 (UMLS CUI [2,2])
Patient Appropriate Placement of stent | Implantation Zotarolimus Drug-Eluting Stent Quantity | Artery Native Target Lesion Quantity
Item
patient is suitable for implantation of one or more endeavor™ zotaroliums eluting coronary stent system in one or more native artery target lesions.
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0522776 (UMLS CUI [1,3])
C0021107 (UMLS CUI [2,1])
C1700035 (UMLS CUI [2,2])
C1322815 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C0003842 (UMLS CUI [3,1])
C0302891 (UMLS CUI [3,2])
C2986546 (UMLS CUI [3,3])
C1265611 (UMLS CUI [3,4])
Patient Indication of Target Lesion | Target Lesion Length | Target Lesion Vessel Diameter
Item
patient indication, lesion length and vessel diameter of the target lesion(s) are according to the indications for use' as mentioned in the 'instructions for use' that comes with every endeavor™ zotarolimus eluting coronary stent system.
boolean
C0030705 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C2986546 (UMLS CUI [1,3])
C2986546 (UMLS CUI [2,1])
C1444754 (UMLS CUI [2,2])
C2986546 (UMLS CUI [3,1])
C0005847 (UMLS CUI [3,2])
C1301886 (UMLS CUI [3,3])
Protocol Compliance
Item
the patient is willing and able to cooperate with registry procedures and required follow up
boolean
C0525058 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
women with known pregnancy or who are lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Aspirin allergy | Heparin allergy | Hypersensitivity Clopidogrel | Hypersensitivity Ticlopidine | Hypersensitivity Zotarolimus | Hypersensitivity Sirolimus | Hypersensitivity Tacrolimus | Hypersensitivity Pharmaceutical Preparations Similar | Hypersensitivity Analogue | Hypersensitivity Derivative | Hypersensitivity Cobalt | Hypersensitivity Chromium | Allergy to nickel | Hypersensitivity Molybdenum | Contrast media allergy
Item
patients with hypersensitivity or allergies to aspirin, heparin, clopidogrel, ticlopidine, drugs such as zotaroliums, rapamycin, tacrolimus, sirolimus or similar drugs, or any other analogue or derivative, cobalt, chromium, nickel, molybdenum or contrast media.
boolean
C0004058 (UMLS CUI [1])
C0571776 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0070166 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0040207 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C1700035 (UMLS CUI [5,2])
C0020517 (UMLS CUI [6,1])
C0072980 (UMLS CUI [6,2])
C0020517 (UMLS CUI [7,1])
C0085149 (UMLS CUI [7,2])
C0020517 (UMLS CUI [8,1])
C0013227 (UMLS CUI [8,2])
C2348205 (UMLS CUI [8,3])
C0020517 (UMLS CUI [9,1])
C0243071 (UMLS CUI [9,2])
C0020517 (UMLS CUI [10,1])
C1527240 (UMLS CUI [10,2])
C0020517 (UMLS CUI [11,1])
C0009148 (UMLS CUI [11,2])
C0020517 (UMLS CUI [12,1])
C0008574 (UMLS CUI [12,2])
C1690547 (UMLS CUI [13])
C0020517 (UMLS CUI [14,1])
C0026402 (UMLS CUI [14,2])
C0570562 (UMLS CUI [15])
Medical contraindication Antiplatelet therapy | Medical contraindication Anticoagulation Therapy
Item
patients in whom anti-platelet and/or anticoagulation therapy is contraindicated.
boolean
C1301624 (UMLS CUI [1,1])
C1096021 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0003281 (UMLS CUI [2,2])
Lesion Preventing Inflation Angioplasty Balloon
Item
patients who are judged to have a lesion that prevents complete inflation of an angioplasty balloon.
boolean
C0221198 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C1283105 (UMLS CUI [1,3])
C0002996 (UMLS CUI [1,4])
Medical condition Resulting in Life Expectancy
Item
current medical condition with a life expectancy of less than 12 months.
boolean
C3843040 (UMLS CUI [1,1])
C0332294 (UMLS CUI [1,2])
C0023671 (UMLS CUI [1,3])
Study Subject Participation Status | Investigational Medical Device | Investigational New Drugs | Clinical Study Follow-up Completed
Item
the subject is participating in another device or drug study. subject must have completed the follow-up phase of any previous study at least 30 days prior to enrollment in this trial. the subject may only be enrolled in this registry once.
boolean
C2348568 (UMLS CUI [1])
C2346570 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
C3274571 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
Medical condition Excludes Clinical Study Follow-up | Medical condition Study Subject Participation Status Limited
Item
patients with medical conditions that preclude the follow-up as defined in the protocol or that otherwise limits participation in this registry.
boolean
C3843040 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])